top of page
Home
About Us
Team
Science
Pipelines
Ulcerative Colitis
Atopic Dermatitis
COVID-19
Diabetes
Nonalcoholic fatty liver disease
Gout
Investor Relations
Contact
More
Use tab to navigate through the menu items.
Investor Relations
SEC Filings
Investor Relations
NEWS / EVENTS
Press Release
Events & Presentations
SEC FILINGS
STOCK INFO
GOVERNANCE
Governance Documents
8/17/26
8-K
Current report
html
8/14/26
10-Q
Quarterly report [Sections 13 or 15(d)]
html
7/21/26
S-8
Securities Registration: Employee Benefit Plan
html
6/29/26
DEF 14C
Other definitive information statements
html
6/18/26
PRE 14C
Preliminary information statements
html
5/14/26
10-Q
Quarterly report [Sections 13 or 15(d)]
html
5/14/26
8-K
Current report
html
5/7/26
8-K
Current report
html
4/2/26
8-K
Current report
html
3/30/26
10-K
Annual report [Section 13 and 15(d), not S-K Item 405]
html
1
2
3
4
5
1
...
1
2
3
4
5
6
7
...
7
bottom of page